{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T17:53:36Z","timestamp":1777312416728,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.jconrel.2006.02.012","type":"journal-article","created":{"date-parts":[[2006,3,8]],"date-time":"2006-03-08T12:21:46Z","timestamp":1141820506000},"page":"280-290","source":"Crossref","is-referenced-by-count":108,"title":["Synthesis and characterization of novel poly(ethylene glycol)-lipid conjugates suitable for use in drug delivery"],"prefix":"10.1016","volume":"112","author":[{"given":"James","family":"Heyes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicky","family":"Tailor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Lenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"MacLachlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2006.02.012_bib1","first-page":"252","article-title":"Progress towards a synthetic virus for systemic gene therapy","volume":"1","author":"MacLachlan","year":"1999","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.jconrel.2006.02.012_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0076-6879(05)91001-X","article-title":"Entrapment of small molecules and nucleic acid-based drugs in liposomes","volume":"391","author":"Fenske","year":"2005","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.jconrel.2006.02.012_bib3","first-page":"95","article-title":"Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules","volume":"133","author":"Dvorak","year":"1988","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jconrel.2006.02.012_bib4","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/bjc.1995.430","article-title":"Sphingomyelin\u2013cholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine in murine and human tumour models","volume":"72","author":"Webb","year":"1995","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2006.02.012_bib5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/j.1552-4604.1996.tb04152.x","article-title":"Doxorubicin encapsulated in liposomes containing surface-found polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma","volume":"36","author":"Northfelt","year":"1996","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jconrel.2006.02.012_bib6","first-page":"575","article-title":"Liposomal vincristine preparations which exhibit decreased drug toxicity and increased activity against murine L1210 and P388 tumors","volume":"50","author":"Mayer","year":"1990","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2006.02.012_bib7","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3109\/10611860009102218","article-title":"Stabilized plasmid-lipid particles: pharmacokinetics and plasmid delivery to distal tumors following intravenous injection","volume":"7","author":"Monck","year":"2000","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2006.02.012_bib8","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1038\/sj.gt.3301308","article-title":"Stabilized plasmid lipid particles for systemic gene therapy","volume":"7","author":"Tam","year":"2000","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2006.02.012_bib9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.bbamem.2005.02.001","article-title":"Stabilized plasmid-lipid particles containing PEG-diacylglycerols exhibit extended circulation lifetimes and tumor selective gene expression","volume":"1669","author":"Ambegia","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2006.02.012_bib10","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0005-2736(00)00343-6","article-title":"Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures","volume":"1510","author":"Semple","year":"2001","journal-title":"Biochim. Biophys. Acta-Biomembr."},{"key":"10.1016\/j.jconrel.2006.02.012_bib11","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/nbt1122","article-title":"Potent and persistent in vivo anti-HBV activity of chemically modified siRNA's","volume":"23","author":"Morrissey","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2006.02.012_bib12","doi-asserted-by":"crossref","first-page":"7413","DOI":"10.1073\/pnas.84.21.7413","article-title":"Lipofection \u2014 a highly efficient, lipid-mediated DNA transfection procedure","volume":"84","author":"Felgner","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2006.02.012_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(97)00128-2","article-title":"Interactions of liposomes and lipid-based carriers with blood proteins: relation to clearance behavior in vivo","volume":"32","author":"Semple","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2006.02.012_bib14","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1021\/bi00411a005","article-title":"Interactions of cationic lipid vesicles with negatively charged phospholipid vesicles and biological membranes","volume":"27","author":"Stamatatos","year":"1988","journal-title":"Biochemistry"},{"key":"10.1016\/j.jconrel.2006.02.012_bib15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0005-2736(95)00268-5","article-title":"Fate of cationic liposomes and their complex with oligonucleotide in vivo","volume":"1281","author":"Litzinger","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2006.02.012_bib16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1021\/bk-1997-0680.ch005","article-title":"Poly(ethylene glycol)-grafted liposome therapeutics","volume":"680","author":"Woodle","year":"1997","journal-title":"ACS Symp. Ser."},{"key":"10.1016\/j.jconrel.2006.02.012_bib17","first-page":"231","article-title":"Long-circulating liposomes","volume":"11","author":"Oku","year":"1994","journal-title":"Crit. Rev. Ther. Drug Carr. Syst."},{"key":"10.1016\/j.jconrel.2006.02.012_bib18","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1021\/bc00030a001","article-title":"New amphipatic polymer lipid conjugates forming long-circulating reticuloendothelial system-evading liposomes","volume":"5","author":"Woodle","year":"1994","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2006.02.012_bib19","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1021\/bc0340363","article-title":"A novel family of l-amino acid-based biodegradable polymer-lipid conjugates for the development of long-circulating liposomes with effective drug-targeting capacity","volume":"14","author":"Metselaar","year":"2003","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2006.02.012_bib20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1078\/0171-9335-00363","article-title":"PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles","volume":"83","author":"Mishra","year":"2004","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.jconrel.2006.02.012_bib21","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0005-2736(98)00077-7","article-title":"Comparison of different hydrophobic anchors conjugated to poly(ethylene glycol): effects on the pharmacokinetics of liposomal vincristine","volume":"1372","author":"Webb","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2006.02.012_bib22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0005-2736(91)90246-5","article-title":"Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo","volume":"1066","author":"Allen","year":"1991","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2006.02.012_bib23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bbamem.2003.10.011","article-title":"Characterization and transfection properties of lipoplexes stabilized with novel exchangeable polyethylene glycol-lipid conjugates","volume":"1660","author":"Rejman","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2006.02.012_bib24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jconrel.2004.11.009","article-title":"Preparation of in vivo cleavable agglomerated liposomes suitable for modulated pulmonary drug delivery","volume":"103","author":"Karathanasis","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2006.02.012_bib25","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1021\/bc990031n","article-title":"New detachable poly(ethylene glycol) conjugates: cysteine-cleavable lipopolymers regenerating natural phospholipid, diacylphosphatidylethanolamine","volume":"10","author":"Zalipsky","year":"1999","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2006.02.012_bib26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-3659(03)00232-3","article-title":"Acid-triggered release via dePEGylation of DOPE liposomes containing acid-labile vinyl ether PEG-lipids","volume":"91","author":"Shin","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2006.02.012_bib27","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/S0006-3495(03)74986-8","article-title":"Mechanism of pH-triggered collapse of phosphatidylethanolamine liposomes stabilized by an ortho ester polyethyleneglycol lipid","volume":"84","author":"Guo","year":"2003","journal-title":"Biophys. J."},{"key":"10.1016\/j.jconrel.2006.02.012_bib28","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1021\/bc025625w","article-title":"Low-pH-sensitive PEG-stabilized plasmid-lipid nanoparticles: preparation and characterization","volume":"14","author":"Choi","year":"2003","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2006.02.012_bib29","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jconrel.2004.07.016","article-title":"pH-sensitive PEG lipids containing orthoester linkers: new potential tools for nonviral gene delivery","volume":"99","author":"Masson","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2006.02.012_bib30","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1124\/jpet.104.078113","article-title":"Immunogenicity and rapid blood clearance of liposomes containing polyethylene glycol-lipid conjugates and nucleic acid","volume":"312","author":"Semple","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2006.02.012_bib31","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ymthe.2005.09.014","article-title":"Hypersensitivity and loss of disease site targeting caused by antibody responses to pegylated liposomes","volume":"13","author":"Judge","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2006.02.012_bib32","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1146\/annurev.immunol.20.100301.064842","article-title":"CpG motifs in bacterial DNA and their immune effects","volume":"20","author":"Krieg","year":"2002","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2006.02.012_bib33","first-page":"421","article-title":"Immune stimulation \u2014 a class effect of phosphorothioate oligodeoxynucleotides in rodents","volume":"12","author":"Monteith","year":"1997","journal-title":"Anti-Cancer Drug Des."},{"key":"10.1016\/j.jconrel.2006.02.012_bib34","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nbt1081","article-title":"Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA","volume":"23","author":"Judge","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2006.02.012_bib35","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jconrel.2005.06.014","article-title":"Degree of cationic lipid saturation influences fusogenicity and subsequent potency of stable plasmid lipid particles","volume":"107","author":"Heyes","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2006.02.012_bib36","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/sj.gt.3300821","article-title":"Stabilized plasmid-lipid particles: construction and characterization","volume":"6","author":"Wheeler","year":"1999","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2006.02.012_bib37","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s11095-004-1873-z","article-title":"A scalable, extrusion-free method for efficient liposomal encapsulation of plasmid DNA","volume":"22","author":"Jeffs","year":"2005","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2006.02.012_bib38","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1021\/jm010918g","article-title":"Synthesis of novel cationic lipids: effect of structural modification on the efficiency of gene transfer","volume":"45","author":"Heyes","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2006.02.012_bib39","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1021\/bc025642l","article-title":"Folate-targeted PEG as a potential carrier for carboplatin analogs. Synthesis and in vitro studies","volume":"14","author":"Aronov","year":"2003","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2006.02.012_bib40","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0076-6879(02)46048-X","article-title":"Stabilized plasmid-lipid particles: a systemic gene therapy vector","volume":"346","author":"Fenske","year":"2002","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.jconrel.2006.02.012_bib41","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/jps.2600820405","article-title":"Hydrolysis of saturated soybean phosphatidylcholine in aqueous liposome dispersions","volume":"82","author":"Grit","year":"1993","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2006.02.012_bib42","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0168-3659(01)00534-X","article-title":"Chemical hydrolysis of DOTAP and DOPE in a liposomal environment","volume":"79","author":"Vernooij","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2006.02.012_bib43","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0006-3495(92)81897-0","article-title":"Sterically stabilized liposomes \u2014 reduction in electrophoretic mobility but not electrostatic surface potential","volume":"61","author":"Woodle","year":"1992","journal-title":"Biophys. J."},{"key":"10.1016\/j.jconrel.2006.02.012_bib44","doi-asserted-by":"crossref","first-page":"18759","DOI":"10.1016\/S0021-9258(19)37026-7","article-title":"Association of blood proteins with large unilamellar liposomes in vivo","volume":"267","author":"Chonn","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2006.02.012_bib45","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/sj.gt.3300837","article-title":"Cationic lipid-mediated transfection of cells in culture requires mitotic activity","volume":"6","author":"Mortimer","year":"1999","journal-title":"Gene Ther."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365906000836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365906000836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T17:35:10Z","timestamp":1627148110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365906000836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0168365906000836"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2006.02.012","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}